Diabetic Nephropathy & Hypertension

Diabetic nephropathy is characterized by hypertension, progressive albuminuria, glomerulosclerosis, and decline in glomerular filtration rate (GFR) leading to ESRD. Hypertension in the setting of diabetes is defined as a systolic blood pressure ≥ 130 mmHg or a diastolic blood pressure ≥ 80 mmHg. An elevated urinary albumin excretion rate, increased blood pressure (BP), and a continual loss of renal function are characteristics of DN. Screening for micro albuminuria is central to diabetes care, and antihypertensive agents are used for the primary prevention and treatment of DN. Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers play central roles and have protective properties beyond their BP-lowering effects. BP control in relation to DN is the main focus of this review, but tight control of the glucose level is equally important.

  • Hypertension Management
  • Pathogenesis of diabetic nephropathy
  • Hypertension-Clinical and Experimental Models
  • Diabetic Nephropathy–Biomarkers of Disease

Related Conference of Diabetic Nephropathy & Hypertension

January 30-31, 2019

4th World Kidney Congress

Abu Dhabi, UAE
February 18-19, 2019

14th Annual Conference on Nephrology & Renal Care

Holiday inn Singapore Atrium, Singapore
February 22-23, 2019

World Kidney Meeting

Dallas, USA
April 08-09, 2019

18th International conference on Nephrology and Therapeutics

Wellington, New Zealand
May 20-21, 2019

15th World Nephrology Conference

Radisson Hotel Narita, Tokyo, Japan
June 03-04, 2019

20th Global Nephrologists Annual Meeting

London, UK
October 09-10, 2019

16th Asia Pacific Nephrology Conference.

Osaka, Japan
October 24-25, 2019

23rd European Nephrology Conference

Rome, Italy
October 24-25, 2019

23rd European Nephrology Conference

Rome, Italy
November 18-19, 2019

2nd International Conference on Nephrology

Dubai, UAE

Diabetic Nephropathy & Hypertension Conference Speakers

Recommended Sessions

Related Journals

Are you interested in